Targeting ferroptosis with the lipoxygenase inhibitor PTC 041 as a therapeutic strategy for the treatment of Parkinson's disease PLOS One Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond G6PD deficiency triggers dopamine loss and the initiation of Parkinson's disease pathogenesis: Cell Reports Ferroptosis related factors in the substantia nigra are associated with Parkinson's disease Scientific Reports Parkinson's disease specific Synuclein variants potentially drive Lewy body formation by engaging in promiscuous and non functional interactions Communications Biology